Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure
- PMID: 25556253
- DOI: 10.1093/infdis/jiu842
Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure
Abstract
Background: Meningococcal conjugate vaccines against serogroups A, C, W, and Y (MenACWY) are recommended for routine use in adolescents aged 11-18 years. The impact of these vaccines on the meningococcal population structure in the United States have yet to be evaluated.
Methods: Meningococcal isolates recovered during 2006-2010 (ie, after introduction of MenACWY) collected through Active Bacterial Core surveillance (ABCs) were characterized; serogroup distribution and molecular features of these isolates were compared to previously published data on ABCs isolates recovered from 2000 to 2005 (ie, before introduction of MenACWY). P values were generated using χ(2) statistics and exact methods.
Results: There was a significant change (P < .05) in serogroup distribution among all age groups between the 2 periods. A small proportion of isolates showed evidence of capsular switching in both periods. Between the 2 periods, significant changes were observed in the distribution of porin A, ferric enterobactin transport, and strain genotypes among vaccine and nonvaccine serogroups.
Conclusions: The population structure of US meningococcal isolates is dynamic; some changes occurred over time, but the basic structure remained. Vaccine-induced serogroup replacement was not observed, although a small proportion of isolates had undergone capsule switching, possibly driven by non-vaccine-mediated selection. Changes in the distribution of molecular features are likely due to horizontal gene transfer and changes in serogroup distribution.
Keywords: meningococcal disease; molecular epidemiology; vaccine impact.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Similar articles
-
Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.Clin Infect Dis. 2018 Apr 3;66(8):1276-1281. doi: 10.1093/cid/cix993. Clin Infect Dis. 2018. PMID: 29126310
-
Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.Vaccine. 2015 Jan 1;33(1):268-75. doi: 10.1016/j.vaccine.2013.09.034. Epub 2013 Oct 6. Vaccine. 2015. PMID: 24103896
-
Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.J Infect Dis. 2018 Jan 30;217(4):608-616. doi: 10.1093/infdis/jix596. J Infect Dis. 2018. PMID: 29155998 Free PMC article.
-
MenACWY-TT vaccine for active immunization against invasive meningococcal disease.Expert Rev Vaccines. 2012 May;11(5):523-37. doi: 10.1586/erv.12.32. Expert Rev Vaccines. 2012. PMID: 22827239 Review.
-
Prospects for vaccine prevention of meningococcal infection.Clin Microbiol Rev. 2006 Jan;19(1):142-64. doi: 10.1128/CMR.19.1.142-164.2006. Clin Microbiol Rev. 2006. PMID: 16418528 Free PMC article. Review.
Cited by
-
Routinely vaccinating adolescents against meningococcus: targeting transmission & disease.Expert Rev Vaccines. 2016 May;15(5):641-58. doi: 10.1586/14760584.2016.1130628. Epub 2016 Mar 4. Expert Rev Vaccines. 2016. PMID: 26651380 Free PMC article. Review.
-
Population structure of invasive Neisseria meningitidis in the United States, 2011-15.J Infect. 2018 Nov;77(5):427-434. doi: 10.1016/j.jinf.2018.06.008. Epub 2018 Jun 30. J Infect. 2018. PMID: 29964139 Free PMC article.
-
Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA.Microb Genom. 2018 Apr;4(4):e000155. doi: 10.1099/mgen.0.000155. Epub 2018 Apr 4. Microb Genom. 2018. PMID: 29616896 Free PMC article.
-
A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae and Streptococcus agalactiae.Microorganisms. 2021 Feb 22;9(2):449. doi: 10.3390/microorganisms9020449. Microorganisms. 2021. PMID: 33671611 Free PMC article. Review.
-
Genomic characterization of invasive meningococcal X isolates from Brazil, 1992-2022.Int Microbiol. 2023 Aug;26(3):611-618. doi: 10.1007/s10123-023-00325-5. Epub 2023 Jan 10. Int Microbiol. 2023. PMID: 36626096 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical